LUCID-EV: a robust and quantitative bioluminescent assay for the detection of EV cytosolic delivery in the absence of VSV-G expression

The paper introduces LUCID-EV, a robust and quantitative bioluminescent assay using HiBiT/LgBiT complementation that enables the detection of cytosolic delivery from non-VSV-G-expressing extracellular vesicles into target immune cells without relying on artificial fusogenic proteins.

The Gist

The Big Picture: The "Secret Message" Problem

Imagine Extracellular Vesicles (EVs) as tiny, waterproof mail bubbles sent out by cells. These bubbles carry important "messages" (proteins, RNA) inside them.

For the message to work, the bubble has to do two things:

1. Get inside the house (the target cell).
2. Break open and drop the message into the living room (the cytosol), not just leave it in the hallway (the endosome).

The Problem: Scientists have been trying to figure out how often these bubbles actually drop their messages into the living room. Previous methods were like trying to see a ghost in a dark room; they often required "cheating" by adding a special "glue" (a protein called VSV-G) to the bubbles to force them to fuse with the cell. Without this glue, the delivery seemed to never happen.

The Solution: The authors created a new, super-sensitive tool called LUCID-EV. Think of it as a bioluminescent "match-and-light" system that can detect if a message has successfully landed in the living room, even without the artificial glue.

---

How the "LUCID-EV" Tool Works

The researchers used a clever trick involving a tiny light source called NanoLuciferase. Imagine this light source is broken into two pieces:

• Piece A (HiBiT): A tiny, 11-letter "spark."
• Piece B (LgBiT): A larger "battery" that needs the spark to light up.

The Setup:

1. The Mail Bubbles (EVs): The researchers put Piece A (the spark) inside the mail bubbles.
2. The Target House (Cells): The target cells are engineered to carry Piece B (the battery) stuck to their inner walls.

The Magic:

• If the bubble stays outside or gets stuck in the hallway, the spark and battery never meet. No light.
• If the bubble successfully enters the house and drops its spark into the living room, the spark hits the battery. FLASH! Light!

The brighter the light, the more successful the delivery.

---

The Three Big Discoveries

1. The "Spark" Needs the Right Backpack

The researchers tried different ways to carry the "spark" (Piece A) inside the bubbles.

• The Old Way: They tried attaching the spark to the bubble's "shell" (like CD9 or CD63 proteins). It was like trying to carry a spark in a heavy, rigid backpack. It worked okay, but the spark couldn't easily reach the battery.
• The New Way: They attached the spark to a lipid-binding domain (LacC2). Think of this as a magnetic grappling hook. It allows the spark to stick to the inner walls of the bubble but also move around freely.
• Result: The "grappling hook" version was much better at lighting up the signal. It proved that how you package the sensor matters just as much as the sensor itself.

2. The "Living Room" Delivery is Real (But Rare)

Using this new, sensitive tool, they tested if bubbles could deliver their contents without the artificial "glue" (VSV-G).

• The Result: Yes! They detected light, meaning the bubbles were delivering their contents into the living room.
• The Catch: It was very inefficient. Out of 10,000 bubbles sent, maybe only 1 successfully dropped its message into the living room.
• Analogy: It's like sending a thousand letters, and only one actually makes it through the mail slot and lands on the desk. It happens, but it's a rare event. This explains why previous studies missed it—they weren't sensitive enough to see that single letter.

3. The "Glue" (VSV-G) Changes the Game

When they did add the artificial glue (VSV-G), the delivery skyrocketed (20 times more efficient).

• The Mechanism: The "glue" forces the bubble to fuse with the cell's outer wall immediately, dumping everything in.
• The Difference: The natural delivery (without glue) happens fast but rarely. The "glue" delivery is slow but happens constantly.
• The Acid Test: They used a drug (Bafilomycin A1) that blocks the "acidic hallway" (endosomes).
  • The "glue" method stopped working (because it relies on the acidic hallway).
  • The natural method kept working.
  • Conclusion: Natural delivery likely happens by the bubble fusing directly with the front door (plasma membrane), bypassing the hallway entirely.

---

Why This Matters

Before this paper, scientists were arguing: "Do cells actually deliver their cargo naturally, or do they need artificial help?"

This paper says: "Yes, they do it naturally, but it's a very delicate, low-efficiency process."

The LUCID-EV assay is like upgrading from a flashlight to a night-vision camera. It allows scientists to finally see these rare, natural events. This is crucial for:

• Understanding Disease: How cancer cells talk to immune cells.
• Drug Delivery: Designing better "mail bubbles" to deliver medicine directly into cells without needing artificial glue.

In a nutshell: The researchers built a super-sensitive light detector that proved cells can naturally drop their cargo into the cytosol, but it's a rare event that requires a very specific setup to be seen.

Technical Summary

1. Problem Statement

Extracellular vesicles (EVs) are critical mediators of intercellular communication, but a central question remains: How efficiently do EVs deliver their luminal cargo (proteins, nucleic acids) into the cytosol of target cells?

• Current Limitations: Existing methods to detect cytosolic delivery often rely on fluorescence or split-luciferase assays. However, these assays frequently fail to detect delivery unless the EVs are artificially engineered to express the fusogenic protein VSV-G (Vesicular Stomatitis Virus G protein), which forces membrane fusion.
• The Gap: There is a lack of robust, quantitative, and sensitive assays capable of detecting natural cytosolic delivery from non-engineered EVs without the artificial enhancement provided by VSV-G. This limits the understanding of physiological EV function.

2. Methodology

The authors developed LUCID-EV (LUCiferase-based Internalization and Delivery of Extracellular Vesicles), an optimized split-nanoluciferase complementation assay.

A. The Split-Luciferase System

• Donor (EVs): Engineered to express the HiBiT tag (11 amino acids) fused to specific sensors.
• Recipient (Target Cells): Engineered to express the LgBiT fragment (large subunit) fused to a membrane-targeting sequence.
• Detection: When HiBiT enters the cytosol and encounters LgBiT, they reconstitute active NanoLuc luciferase, producing a luminescent signal upon addition of the substrate furimazine.

B. Optimization Strategies

To overcome previous failures, the authors optimized three key parameters:

1. HiBiT Loading into EVs:
   • Tested two strategies: Fusion to transmembrane tetraspanins (CD9, CD63) vs. fusion to soluble lipid-binding domains.
   • Selection: The HiBiT-LacC2 sensor (fused to the C2 domain of MFGE8/Lactadherin, which binds phosphatidylserine) proved superior. It showed high loading efficiency and better accessibility for LgBiT interaction compared to direct tetraspanin fusions.
2. LgBiT Localization:
   • To maximize interaction with membrane-bound HiBiT sensors, LgBiT was fused to a myristoylation (myrpalm) sequence. This targets LgBiT to the cytosolic leaflet of the plasma membrane, increasing the probability of collision with delivered HiBiT.
3. Signal-to-Noise Ratio:
   • Added an excess of DarkBit (DkB), an inhibitory peptide that competes for LgBiT binding but produces no light. This blocks background luminescence caused by cell leakage or extracellular HiBiT, ensuring the signal comes strictly from internalized cargo.

C. Experimental Setup

• Donor Cells: E0771 (mouse breast cancer), MDA-MB-231 (human breast cancer), HEK293, and MutuDC cells expressing HiBiT-LacC2.
• Recipient Cells: MutuDC dendritic cells expressing membrane-targeted mpLgBiT.
• Controls: Experiments were conducted at 4°C (to inhibit uptake) and with VSV-G expression to compare mechanisms. EVs were isolated via Size Exclusion Chromatography (SEC) or used as concentrated conditioned media (CCM).

3. Key Results

A. Validation of the Assay

• Specificity: The assay successfully distinguished between EV uptake and cytosolic delivery. Delivery was detected as early as 15 minutes, peaking at 30–60 minutes.
• Sensitivity: The assay detected cytosolic delivery from non-VSV-G expressing EVs, a feat previously unachievable with standard split-luciferase methods.
• Quantification: Cytosolic delivery was found to be dose-dependent but had low absolute efficiency (approx. 0.01% of input EVs delivered cargo to the cytosol), highlighting the need for such a sensitive assay.

B. Mechanism of Delivery

• VSV-G Independence: Natural EVs from E0771 and other cell lines delivered cargo without VSV-G.
• Mechanism Distinction:
  • Natural Delivery: Not inhibited by Bafilomycin A1 (an inhibitor of endosomal acidification). This suggests the delivery occurs via direct fusion with the plasma membrane or a non-acidic pathway, rather than the endosomal escape route required for VSV-G.
  • VSV-G Delivery: When VSV-G was expressed, delivery efficiency increased 20-fold. Crucially, this VSV-G-mediated delivery was abolished by Bafilomycin A1, confirming it relies on the acidic endosomal environment.
• Kinetics: Natural delivery showed fast kinetics (plateauing at 1 hour), whereas VSV-G delivery continued to increase over 4 hours.

C. Generalizability

• The assay worked across EVs from different species (mouse and human) and cell types (cancer, kidney, immune).
• It successfully detected delivery from both Small EVs and Viral-Like Particles (VLPs) secreted by E0771 cells.

4. Key Contributions

1. Development of LUCID-EV: A highly sensitive, quantitative, and robust assay that eliminates the need for artificial fusogens (VSV-G) to detect cytosolic delivery.
2. Optimization of Split-Luciferase: Demonstrated that fusing HiBiT to lipid-binding domains (LacC2) and targeting LgBiT to the plasma membrane significantly improves detection sensitivity compared to traditional tetraspanin fusions.
3. Mechanistic Insight: Provided evidence that physiological EVs can deliver cargo to the cytosol via a plasma membrane fusion mechanism that is distinct from the VSV-G/endosomal pathway.
4. Quantitative Baseline: Established that while natural cytosolic delivery is a real phenomenon, it is a low-efficiency process (0.01%), explaining why it was previously difficult to detect.

5. Significance

• Resolving Controversy: The study supports the hypothesis that EVs act as natural intercellular messengers capable of cytosolic delivery without artificial manipulation, addressing recent debates in the field.
• Methodological Advance: LUCID-EV provides a standardized tool for researchers to screen EV/target cell pairs for enhanced delivery properties and to characterize the specific cellular routes (plasma membrane vs. endosomal) used by different EV populations.
• Therapeutic Implications: Understanding the low efficiency of natural delivery is crucial for developing EV-based drug delivery systems. The assay allows for the identification of conditions or EV subtypes that might naturally enhance this delivery, potentially reducing the need for harsh engineering or fusogenic proteins in therapeutic applications.